Vertex Pharma (VRTX) Misses Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $528.04 +6.03%
Revenue Growth %: +8.4%
Financial Fact:
Sales, general and administrative expenses: 106.06M
Today's EPS Names:
CRMT, More
Revenue Growth %: +8.4%
Financial Fact:
Sales, general and administrative expenses: 106.06M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q3 EPS of ($0.39), $0.09 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $309.8 million versus the consensus estimate of $245.84 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- General Mills (GIS) PT Lowered to $42 at Freedom Broker
- Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
